The landscape of malignancy treatment is constantly evolving, with a growing focus on identifying novel therapeutic targets for drug development. Traditional therapies often strike rapidly dividing cells, leading to significant side consequences. However, the emergence of sophisticated genomic profiling techniques has revolutionized our knowledge o